Search results for "Subcutaneous"

showing 10 items of 162 documents

External Volume Expansion Increases Subcutaneous Thickness, Cell Proliferation, and Vascular Remodeling in a Murine Model

2012

Background Fat grafting is a powerful tool for soft-tissue reconstruction; however, the science behind recipient bed preparation has not been thoroughly explored. External volume expansion using suction before fat grafting has been used clinically to improve reliability and consistency of graft survival. The authors developed a murine model to investigate the underlying mechanism of external volume expansion. Methods The authors created an external volume expansion device using a soft-silicone dome connected to a vacuum source (25 mmHg) to treat the dorsum of mice, and the response was compared with treatment with an occlusive dressing. Treated areas were monitored with magnetic resonance i…

Suctionmedicine.diagnostic_testCell growthbusiness.industryMagnetic resonance imagingOcclusive dressingmedicine.anatomical_structuremedicineSurgerySwellingmedicine.symptombusinessCorrosion CastingBiomedical engineeringSubcutaneous tissueBlood vesselPlastic & Reconstructive Surgery
researchProduct

Priming with a combination of proangiogenic growth factors improves wound healing in normoglycemic mice

2011

Growth factors and/or angiogenic factors are supposed to improve wound healing. The aim of our study was to evaluate the effects of subcutaneous pretreatment with combinatory proangiogenic factors on wound closure, mechan - ical properties, vessel density and morphology. Twenty-eight Balb/c mice were divided equally into two groups. A mixture of VEGF (35.0 µg), bFGF (2.5 µg) and P dGF (3.5 µg) was administered subcutaneously 3, 5 and 7 days to 14 mice before full thickness skin punch biopsy wounding, whereas 14 control animals received three injections of 0.2 ml saline solution. Wound sizes were assessed daily and the repaired tissues were harvested 7 days after complete wound closure. Comp…

Vascular Endothelial Growth Factor Amedicine.medical_specialtyPlatelet-derived growth factormedicine.medical_treatmentInjections SubcutaneousUrologyPriming (immunology)Neovascularization PhysiologicArticlechemistry.chemical_compoundMiceSkin Physiological PhenomenaTensile StrengthGeneticsmedicineAnimalsRegenerationSalineSkinPlatelet-Derived Growth FactorMice Inbred BALB CWound HealingOncogeneintegumentary systembusiness.industryGeneral MedicineMolecular medicineSurgeryVascular endothelial growth factor ADrug CombinationsCollagen Type IIIchemistryApoptosisThermographyBlood VesselsAngiogenesis Inducing AgentsFemaleFibroblast Growth Factor 2Wound healingbusiness
researchProduct

Development of a non-invasive LED based device for adipose tissue thickness measurements in vivo

2012

There are a number of techniques for body composition assessment in clinics and in field-surveys, but in all cases the applied methods have advantages and disadvantages. High precision imaging methods are available, though expensive and non-portable, however, the methods devised for the mass population, often suffer from the lack of precision. Therefore, the development of a safe, mobile, non-invasive, optical method that would be easy to perform, precise and low-cost, but also would offer an accurate assessment of subcutaneous adipose tissue (SAT) both in lean and in obese persons is required. Thereof, the diffuse optical spectroscopy is advantageous over the aforementioned techniques. A p…

education.field_of_studyMaterials sciencebusiness.industryNon invasivePopulationMultispectral imageAdipose tissueOpticsmedicine.anatomical_structureIn vivomedicineSubcutaneous adipose tissueUltrasonographyeducationbusinessSubcutaneous tissueSPIE Proceedings
researchProduct

Non-Articular Rheumatism

1975

In terms of numbers of the population involved, this type of rheumatism is of the greatest significance.

education.field_of_studyPathologymedicine.medical_specialtybusiness.industryPopulationmedicine.diseaseGiant cell arteritisTendon sheathmedicineArticular rheumatismRheumatic feverSubcutaneous adipose tissueeducationbusinessRheumatismConnective tissue cell
researchProduct

Reply to: Letters to the article “Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in…

2010

glycaemic variability diabetes continuous subcutaneous glucose monitoring
researchProduct

Capsaicin desensitization in vivo is inhibited by ruthenium red.

1990

The effect of systemic administration of Ruthenium Red on the excitatory and desensitizing effect of capsaicin was investigated in rats. Ruthenium Red was injected s.c. 30 min before capsaicin was administered. The excitatory effect of capsaicin on corneal, perivascular and visceral afferents was not influenced by treatment with Ruthenium Red. However, determination of the neuropeptide content and evoked neuropeptide release in peripheral organs and dorsal spinal cord 48 h after treatment showed that Ruthenium Red attenuated the 'desensitizing' effect of capsaicin at peripheral, but not at central, endings of primary afferents. On the other hand, a capsaicin-elicited autonomic reflex mediat…

inorganic chemicalsRuthenium redCalcitonin Gene-Related PeptideInjections SubcutaneousCentral nervous systemUrinary BladderNeuropeptideBlood PressurePharmacologySubstance PSynaptic Transmissionchemistry.chemical_compoundIn vivootorhinolaryngologic diseasesAutonomic reflexmedicineAnimalsNeurons AfferentPharmacologyNerve EndingsNeuronsChemistryNeuropeptidesRats Inbred StrainsRuthenium RedRatsmedicine.anatomical_structureCapsaicinAnesthesiaExcitatory postsynaptic potentiallipids (amino acids peptides and proteins)NeuronCapsaicinEuropean journal of pharmacology
researchProduct

TLR7 controls VSV replication in CD169(+) SCS macrophages and associated viral neuroinvasion

2019

Vesicular stomatitis virus (VSV) is an insect-transmitted rhabdovirus that is neurovirulent in mice. Upon peripheral VSV infection, CD169+ subcapsular sinus (SCS) macrophages capture VSV in the lymph, support viral replication, and prevent CNS neuroinvasion. To date, the precise mechanisms controlling VSV infection in SCS macrophages remain incompletely understood. Here, we show that Toll-like receptor-7 (TLR7), the main sensing receptor for VSV, is central in controlling lymph-borne VSV infection. Following VSV skin infection, TLR7−/− mice display significantly less VSV titers in the draining lymph nodes (dLN) and viral replication is attenuated in SCS macrophages. In contrast to effects o…

lcsh:Immunologic diseases. Allergy0301 basic medicinevirusesImmunologyMedizinDENDRITIC CELLSRIG-IACTIVATION03 medical and health sciences0302 clinical medicinesubcapsular sinus macrophagesSUBCAPSULAR SINUS MACROPHAGESImmunitySIMULIUM-VITTATUM DIPTERAINFECTIONImmunology and Allergyinnate immunityvirus replicationHost factorconditional knock-out miceInnate immune systemScience & TechnologyLYMPH-NODESbiologysubcutaneous infectionPattern recognition receptorpattern recognition receptorsvirus diseasesTLR7VESICULAR STOMATITIS-VIRUSbiology.organism_classificationVirologyddc:Toll-like receptor 7stomatognathic diseases030104 developmental biologyViral replicationVesicular stomatitis virusNEW-JERSEY SEROTYPEINNATE IMMUNITYvesicular stomatitis viruslcsh:RC581-607Viral loadLife Sciences & Biomedicine030215 immunology
researchProduct

Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled rando…

2019

Abstract Background Hereditary angioedema (HAE) is a debilitating disorder resulting from C1-esterase inhibitor (C1-INH) deficiency. In the COMPACT phase 3 study the prophylactic use of a subcutaneous C1 inhibitor (C1-INH [SC], HAEGARDA®, CSL Behring) twice weekly significantly reduced the frequency of acute edema attacks. Analysis of treatment effects by subgroups, onset of effect, and other exploratory analysis have not been reported. Methods This is a post hoc exploratory analysis on data from the randomized, placebo-controlled COMPACT study. 90 patients with C1-INH-HAE were randomized to 1 of 4 treatment sequences: C1-INH (SC) 40 or 60 IU/kg of body weight twice weekly for 16 weeks, pre…

lcsh:Immunologic diseases. Allergymedicine.medical_specialtyPhases of clinical researchSubgroup analysisReplacement therapyPlacebolaw.invention03 medical and health sciences0302 clinical medicineC1-INH (SC)Randomized controlled trialHAEGARDA®lawInternal medicinePost-hoc analysisMedicine030212 general & internal medicineDosingCOMPACT studyHereditary angioedemabusiness.industryResearchSubcutaneousGeneral Medicinemedicine.diseaseClinical trialLong-term prophylaxis030228 respiratory systemC1-esterase inhibitor proteinHereditary angioedemabusinesslcsh:RC581-607Allergy, Asthma & Clinical Immunology
researchProduct

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges

2020

AbstractHemophilia A (HA) and B (HB) are X-linked bleeding disorders caused by mutations in the F8 or F9 gene that result in the absence, or reduced activity, of the corresponding clotting factor. The severity of bleeding and related complications is proportional to the amount of residual circulating functional factor. The development of a safe and effective hemophilia treatment lasted several decades and has been mainly based on clotting factor replacement. Advances in the engineering and manufacturing of clotting concentrates have led to the widespread availability of extended half-life products that reduced the number of intravenous infusions needed to achieve adequate trough levels. The…

medicine.medical_specialtyAcetylgalactosamineInjections SubcutaneousLipoproteinsHemorrhage030204 cardiovascular system & hematologyAntibodies Monoclonal HumanizedHemophilia AHemophilia BSeverity of Illness IndexDisease courseFactor IX03 medical and health sciencesRoute of administrationLife Expectancy0302 clinical medicineAntibodies BispecificmedicineHumansRNA Small InterferingInfusions IntravenousIntensive care medicineFactor IXClotting factorClinical Trials as TopicFactor VIIICoagulantsbusiness.industryGenetic TherapyHematologyIntravenous InfusionsHistory 20th CenturyBlood Coagulation FactorsLaboratoriesbusiness030215 immunologymedicine.drugHämostaseologie
researchProduct

Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study

2003

medicine.medical_specialtyBotulinum ToxinsInjections SubcutaneousTreatment outcomePilot ProjectsSweatingDermatologyAxillary hyperhidrosismedicineHumansHyperhidrosisBotulinum Toxins Type AInjections subcutaneousHyperhidrosisbusiness.industryLow doseGeneral MedicineDermatologyBotulinum toxinSurgeryAxillaAutonomic nervous systemTreatment Outcomemedicine.anatomical_structureAxillamedicine.symptombusinessmedicine.drugArchives of Dermatological Research
researchProduct